Nasdaq:US$12.13 (-0.47) | HKEX:HK$18.80 (-0.60) | AIM:£2.00 (+0)
Search
Announcements
12345678910111213
14
found Documents: 687
Announcements & Press Releases, Regulatory Notice | 2 Jun 2008

Board Change
a080602
Announcements & Press Releases, Other Ventures | 23 May 2008

China Healthcare Division Chi-Med increases ownership of its Hutchison Healthcare joint venture
a080523
Announcements & Press Releases, Other Ventures | 19 May 2008

Expansion of Consumer Products division Sen launches in 125 Marionnaud beauty stores
a080519
Announcements & Press Releases, Regulatory Notice | 9 May 2008

Results of Annual General Meeting
a080509
Announcements & Press Releases, Regulatory Notice | 22 Apr 2008

Holding in Company
a080422
Announcements & Press Releases, Regulatory Notice | 9 Apr 2008

Annual Report 2007 and Notice of Annual General Meeting
a080409
Announcements & Press Releases, Regulatory Notice | 31 Mar 2008

Holding in Company
a080331
Announcements & Press Releases, Group | 19 Mar 2008

Preliminary Results for the year ended 31 December 2007
a080319
Announcements & Press Releases, Oncology / Immunology | 29 Feb 2008

Chi-Med Announces Start of Patient Enrolment in a Global Phase IIb Ulcerative Colitis Clinical Trial of HMPL-004, its Leading Anti-Inflammatory Drug Candidate
a080229
Announcements & Press Releases, Regulatory Notice | 28 Feb 2008

Change in the Registered Office Address in the Cayman Islands
a080228a
Announcements & Press Releases, Regulatory Notice | 28 Feb 2008

Notice of 2007 Preliminary Results
a080228
Announcements & Press Releases, Other Ventures | 21 Jan 2008

Strong growth in China Healthcare divisionStreamlining of product range set to further improve financial performance
a080121
Announcements & Press Releases, Regulatory Notice | 27 Dec 2007

Block Admission Return
a071227
Announcements & Press Releases, Oncology / Immunology | 22 Nov 2007

Chi-Med Plans to Initiate Global Phase IIb Trials of its Lead Anti-Inflammatory Drug Candidate, HMPL-004, in Ulcerative Colitis Patients
a071122
Announcements & Press Releases, Oncology / Immunology | 20 Aug 2007

Chi-Med Announces Drug Discovery and Development Agreement with Eli Lilly and Company
a070820
Announcements & Press Releases, Group | 9 Aug 2007

Interim Results for the Six Months Ended 30 June 2007
a070809
Announcements & Press Releases, Regulatory Notice | 18 Jul 2007

Notice of Interim Results
a070718
Announcements & Press Releases, Oncology / Immunology | 2 Jul 2007

Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
a070702
Announcements & Press Releases, Regulatory Notice | 22 Jun 2007

Block Admission
a070622
Announcements & Press Releases, Oncology / Immunology | 18 Jun 2007

Chi-Med locks-in property gain and protects low cost R&D structure through acquisition of Shanghai facility
a070618
Announcements & Press Releases, Oncology / Immunology | 23 May 2007

Chi-Med completes patient enrolment on its HMPL-004 ulcerative colitis proof-of-concept; Phase II clinical trial in China
a070523
Announcements & Press Releases, Regulatory Notice | 22 May 2007

Director's Shareholding
a070522
Announcements & Press Releases, Regulatory Notice | 11 May 2007

Results of Annual General Meeting
a070511
Announcements & Press Releases, Regulatory Notice | 12 Apr 2007

Annual Report and Accounts 2006 - Notice of Annual General Meeting
a070412
Announcements & Press Releases, Regulatory Notice | 2 Apr 2007

Board Change
a070402
Announcements & Press Releases, Regulatory Notice | 23 Mar 2007

Director's Shareholding
a070323
Announcements & Press Releases, Group | 21 Mar 2007

Preliminary Results for the year ended 31 December 2006
a070321
Announcements & Press Releases, Regulatory Notice | 26 Feb 2007

Notice of Preliminary Results
a070226
Announcements & Press Releases, Other Ventures | 17 Jan 2007

Related party transaction Chi-Med formalises China Sales and Distribution Arrangements
a070117
Announcements & Press Releases, Regulatory Notice | 5 Jan 2007

Appointment of Joint Broker
a070105
Announcements & Press Releases, Oncology / Immunology | 20 Nov 2006

Chi-Med and Merck KGaA Start Collaboration to Discover Novel Small Molecule Anti-Cancer Drugs
a061120
Announcements & Press Releases, Oncology / Immunology | 6 Nov 2006

Development Agreement with Procter & Gamble for the Discovery and Development of New Active Ingredients for Beauty Products
a061106
Announcements & Press Releases, Regulatory Notice | 29 Sep 2006

Appointment of Senior Independent Director
a060929
Announcements & Press Releases, Group | 9 Aug 2006

Financial Results for the Six Months Ended 30 June 2006
p060809
Announcements & Press Releases, Regulatory Notice | 26 Jul 2006

Notice of Maiden Interim Results
a060726
Announcements & Press Releases, Group | 17 Jul 2006

Trading Update
a060717
Announcements & Press Releases, Oncology / Immunology | 4 Jul 2006

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate
a060704
12345678910111213
14